Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1992 Oct;60(10):4239–4244. doi: 10.1128/iai.60.10.4239-4244.1992

Similarity between the group B and A streptococcal C5a peptidase genes.

P P Cleary 1, J Handley 1, A N Suvorov 1, A Podbielski 1, P Ferrieri 1
PMCID: PMC257458  PMID: 1398935

Abstract

Group B streptococci (GBS) and group A streptococci (GAS) are known to have surface-associated peptidase activity which specifically cleaves C5a (C5a-ase), the primary chemotaxin for polymorphonuclear leukocytes. Amplification products were obtained from GBS genomic DNA template by using the polymerase chain reaction and primers corresponding to the C5a peptidase gene of GAS (scpA12). A restriction map of the GBS full-length amplified gene (scpB) was developed. The scpB restriction map was found to be highly similar to that of the analogous gene in GAS. A 50-bp deletion was located near the 5' end of scpB in a region where repeat sequences are found in scpA12. Hybridization experiments confirmed that other serotypes of GBS also carry an scpB-like gene. These results show that GBS contain a gene, scpB, which is very similar to that harbored by M12 GAS. The probability that scpB encodes the C5a-ase protein is discussed.

Full text

PDF
4239

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bohnsack J. F., Mollison K. W., Buko A. M., Ashworth J. C., Hill H. R. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem J. 1991 Feb 1;273(Pt 3):635–640. doi: 10.1042/bj2730635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bohnsack J. F., Zhou X. N., Williams P. A., Cleary P. P., Parker C. J., Hill H. R. Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta. 1991 Aug 30;1079(2):222–228. doi: 10.1016/0167-4838(91)90129-n. [DOI] [PubMed] [Google Scholar]
  3. Bollet C., Gevaudan M. J., de Lamballerie X., Zandotti C., de Micco P. A simple method for the isolation of chromosomal DNA from gram positive or acid-fast bacteria. Nucleic Acids Res. 1991 Apr 25;19(8):1955–1955. doi: 10.1093/nar/19.8.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen C. C., Cleary P. P. Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene. Infect Immun. 1989 Jun;57(6):1740–1745. doi: 10.1128/iai.57.6.1740-1745.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen C. C., Cleary P. P. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem. 1990 Feb 25;265(6):3161–3167. [PubMed] [Google Scholar]
  6. Cleary P. P., Peterson J., Chen C., Nelson C. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun. 1991 Jul;59(7):2305–2310. doi: 10.1128/iai.59.7.2305-2310.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Erlich H. A., Gelfand D., Sninsky J. J. Recent advances in the polymerase chain reaction. Science. 1991 Jun 21;252(5013):1643–1651. doi: 10.1126/science.2047872. [DOI] [PubMed] [Google Scholar]
  8. Hemming V. G., McCloskey D. W., Hill H. R. Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child. 1976 Nov;130(11):1231–1233. doi: 10.1001/archpedi.1976.02120120065011. [DOI] [PubMed] [Google Scholar]
  9. Hill H. R., Bohnsack J. F., Morris E. Z., Augustine N. H., Parker C. J., Cleary P. P., Wu J. T. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol. 1988 Nov 15;141(10):3551–3556. [PubMed] [Google Scholar]
  10. O'Connor S. P., Cleary P. P. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis. 1987 Sep;156(3):495–504. doi: 10.1093/infdis/156.3.495. [DOI] [PubMed] [Google Scholar]
  11. Podbielski A., Melzer B., Lütticken R. Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci. Med Microbiol Immunol. 1991;180(4):213–227. doi: 10.1007/BF00215250. [DOI] [PubMed] [Google Scholar]
  12. Robbins J. C., Spanier J. G., Jones S. J., Simpson W. J., Cleary P. P. Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol. 1987 Dec;169(12):5633–5640. doi: 10.1128/jb.169.12.5633-5640.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rubens C. E., Wessels M. R., Heggen L. M., Kasper D. L. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7208–7212. doi: 10.1073/pnas.84.20.7208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Russell-Jones G. J., Gotschlich E. C., Blake M. S. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med. 1984 Nov 1;160(5):1467–1475. doi: 10.1084/jem.160.5.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  16. Siezen R. J., de Vos W. M., Leunissen J. A., Dijkstra B. W. Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases. Protein Eng. 1991 Oct;4(7):719–737. doi: 10.1093/protein/4.7.719. [DOI] [PubMed] [Google Scholar]
  17. Wexler D. E., Cleary P. P. Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect Immun. 1985 Dec;50(3):757–764. doi: 10.1128/iai.50.3.757-764.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wexler D. E., Nelson R. D., Cleary P. P. Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun. 1983 Jan;39(1):239–246. doi: 10.1128/iai.39.1.239-246.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES